Effect of white-colored mineral trioxide aggregate in different concentrations on Candida albicans in vitro.
The antifungal action of different concentrations of white-colored mineral trioxide aggregate (MTA) against Candida albicans was assessed in vitro. Fresh mix of MTA was prepared at concentrations varying from 0.78 mg/ml to 50 mg/ml by dilution with 10 ml molten agar at 45 degrees C. The MTA-agar compound was thoroughly mixed and the uniform mix was then poured into sterile Petri dishes and allowed to set. A total of 348 agar plates were prepared and divided into experimental groups of 11 plates each and control groups of 5 plates each. Plates of agar without MTA served as positive control and plates without C. albicans served as negative control. Fresh inoculate of C. albicans was prepared by growing an overnight culture from a stock culture. Aliquots of C. albicans were then taken from the stock culture and plated on the agar compound of the experimental and positive control groups. All plates were incubated at 37 degrees C for 1, 24, 48, and 72-h periods. At each time period, the presence of C. albicans colonies was assessed and recorded. A direct correlation was found between MTA concentration and its inhibition effect on C. albicans growth. Plates containing MTA in concentration of 50 mg/ml showed significantly better killing action against C. albicans in all of the time periods tested (p < 0.001). Plates containing MTA in concentration of 25 mg/ml showed antifungal activity only at 1 and 24-h time periods. Plates containing lower concentrations of MTA did not show any antifungal activity. It appears that under the conditions of this study, white-colored MTA in concentration of 50 mg/ml is effective in killing C. albicans for periods of up to 3 days. Lower MTA concentrations may not be effective.
Al-Hezaimi
Khalid
K
King Saud University, College of Dentistry, Riyadh, Saudi Arabia.
Al-Hamdan
Khalid
K
Naghshbandi
Jafar
J
Oglesby
Samuel
S
Simon
James H S
JH
Rotstein
Ilan
I
D017607:Aluminum Compounds / Q000008:administration & dosage*; D000935:Antifungal Agents / Q000008:administration & dosage*; D017610:Calcium Compounds / Q000008:administration & dosage*; D002176:Candida albicans / Q000187:drug effects*; D003116:Color; D004338:Drug Combinations; D004353:Drug Evaluation, Preclinical; D010087:Oxides / Q000008:administration & dosage*; D017640:Silicates / Q000008:administration & dosage*
D017607:Aluminum Compounds; D000935:Antifungal Agents; D017610:Calcium Compounds; D004338:Drug Combinations; D010087:Oxides; D017640:Silicates; C086631:mineral trioxide aggregate